AERAS Trademark

Trademark Overview

On Tuesday, June 17, 2003, a trademark application was filed for AERAS with the United States Patent and Trademark Office. The USPTO has given the AERAS trademark a serial number of 76523863. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, December 1, 2016. This trademark is owned by Sequella Global Tuberculosis Foundation. The AERAS trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:

CUSTOM MANUFACTURING OF VACCINES FOR TREATING AND PREVENTING TUBERCULOSIS TO ORDER AND/OR SPECIFICATION OF OTHERS

SCIENTIFIC AND MEDICAL RESEARCH SERVICES, NAMELY, CONDUCTING RESEARCH AND CLINICAL TRIALS TO DEVELOP AND TEST NEW VACCINES FOR TREATING AND PREVENTING TUBERCULOSIS; TECHNICAL AND SCIENTIFIC CONSULTATION IN THE FIELD OF DEVELOPING AND TESTING NEW VACCINES FOR TREATING AND PREVENTING TUBERCULOSIS
aeras

General Information

Serial Number76523863
Word MarkAERAS
Filing DateTuesday, June 17, 2003
Status800 - REGISTERED AND RENEWED
Status DateThursday, December 1, 2016
Registration Number3145863
Registration DateTuesday, September 19, 2006
Mark Drawing1 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 27, 2005

Trademark Statements

Goods and ServicesCUSTOM MANUFACTURING OF VACCINES FOR TREATING AND PREVENTING TUBERCULOSIS TO ORDER AND/OR SPECIFICATION OF OTHERS
Translation of Words in MarkThe term "AERAS" means "lung" in Greek.
Goods and ServicesSCIENTIFIC AND MEDICAL RESEARCH SERVICES, NAMELY, CONDUCTING RESEARCH AND CLINICAL TRIALS TO DEVELOP AND TEST NEW VACCINES FOR TREATING AND PREVENTING TUBERCULOSIS; TECHNICAL AND SCIENTIFIC CONSULTATION IN THE FIELD OF DEVELOPING AND TESTING NEW VACCINES FOR TREATING AND PREVENTING TUBERCULOSIS

Classification Information

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateMonday, August 9, 2004
Primary Code040
First Use Anywhere DateFriday, October 31, 2003
First Use In Commerce DateFriday, October 31, 2003
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, July 3, 2003
Primary Code042
First Use Anywhere DateFriday, October 31, 2003
First Use In Commerce DateFriday, October 31, 2003

Trademark Owner History

Party NameAERAS
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressROCKVILLE, MD 20850
Party NameAERAS GLOBAL TB VACCINE FOUNDATION
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBethesda, MD 20814
Party NameAERAS GLOBAL TB VACCINE FOUNDATION
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBethesda, MD 20814
Party NameAERAS GLOBAL TB VACCINE FOUNDATION
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressROCKVILLE, MD 20850
Party NameSequella Global Tuberculosis Foundation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Trademark Events

Event DateEvent Description
Tuesday, December 23, 2003TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, December 23, 2003UNRESPONSIVE/DUPLICATE PAPER RECEIVED
Saturday, December 27, 2003ASSIGNED TO EXAMINER
Tuesday, December 30, 2003PAPER RECEIVED
Sunday, December 7, 2003TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 23, 2003TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, December 29, 2003NON-FINAL ACTION MAILED
Monday, August 9, 2004EXAMINER'S AMENDMENT ENTERED
Tuesday, August 24, 2004EXAMINERS AMENDMENT MAILED
Monday, September 27, 2004EXAMINERS AMENDMENT -WRITTEN
Wednesday, September 29, 2004ASSIGNED TO LIE
Wednesday, April 27, 2005EXAMINER'S AMENDMENT ENTERED
Monday, June 28, 2004PAPER RECEIVED
Monday, June 28, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 28, 2004AMENDMENT FROM APPLICANT ENTERED
Monday, September 6, 2004APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, September 27, 2004PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, September 27, 2004EXAMINERS AMENDMENT MAILED
Thursday, May 12, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 7, 2005NOTICE OF PUBLICATION
Tuesday, September 27, 2005PUBLISHED FOR OPPOSITION
Tuesday, December 20, 2005NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 20, 2006SOU TEAS EXTENSION RECEIVED
Tuesday, June 20, 2006SOU EXTENSION 1 FILED
Tuesday, June 20, 2006SOU EXTENSION 1 GRANTED
Wednesday, June 21, 2006TEAS STATEMENT OF USE RECEIVED
Wednesday, June 21, 2006USE AMENDMENT FILED
Saturday, July 15, 2006STATEMENT OF USE PROCESSING COMPLETE
Friday, July 21, 2006ASSIGNED TO LIE
Tuesday, September 19, 2006REGISTERED-PRINCIPAL REGISTER
Wednesday, September 19, 2012AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, June 6, 2005ASSIGNED TO LIE
Monday, June 13, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, February 14, 2006ASSIGNED TO EXAMINER
Wednesday, July 19, 2006ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, July 31, 2006LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, September 14, 2012TEAS SECTION 8 & 15 RECEIVED
Thursday, September 27, 2012NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, September 19, 2015COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, September 19, 2016TEAS SECTION 8 & 9 RECEIVED
Thursday, December 1, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, December 1, 2016REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, December 1, 2016REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, September 19, 2025COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, December 1, 2016NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Wednesday, September 26, 2012CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, September 26, 2012REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Related Keywords

aeras preventing treating vaccines tuberculosis scientific research test develop trials technical